AbilTo completes Series A financing to expand proprietary technology and programs platform AbilTo.


AbilTo completes Series A financing to expand proprietary technology and programs platform AbilTo, Inc., a business that delivers verified behavioral health programs to help adults overcome slight and moderate depression associated with major medical occasions, announced today the completion of a $3 million round of Series A funding to fund the growth of the Company's proprietary technology and applications platform http://tadalafilo.org . The financing circular was led by .406 Ventures. AbilTo functions through health plans and employers to provide remotely delivered behavioral health programs via mobile phone or secure video link.

Abbott’s ongoing earnings-per-share guidance for full-12 months 2011 can be $4.64 to $4.66, excluding specified products, reflecting 11.5 % growth at the midpoint of the number. Strong overall performance across our businesses allowed Abbott to continue to provide superior results, said Miles D. White, chairman and chief executive officer, Abbott. We also experienced strong growth in emerging marketplaces and success inside our broad-centered pipeline, including several new item approvals, regulatory submissions and medical trial initiations. About Abbott Abbott is a global, broad-based health care company devoted to the discovery, development, produce and advertising of pharmaceuticals and medical items, including nutritionals, devices and diagnostics.